Equities Analysts Set Expectations for Cryoport, Inc.’s FY2022 Earnings (NASDAQ:CYRX)

Cryoport, Inc. (NASDAQ:CYRXGet Rating) – Equities researchers at Jefferies Financial Group cut their FY2022 earnings per share estimates for shares of Cryoport in a report issued on Wednesday, November 16th. Jefferies Financial Group analyst B. Couillard now expects that the consumer goods maker will earn ($0.91) per share for the year, down from their prior estimate of ($0.78). The consensus estimate for Cryoport’s current full-year earnings is ($0.88) per share. Jefferies Financial Group also issued estimates for Cryoport’s Q4 2022 earnings at ($0.22) EPS, Q1 2023 earnings at ($0.05) EPS, Q2 2023 earnings at ($0.06) EPS, Q3 2023 earnings at ($0.06) EPS, Q4 2023 earnings at ($0.05) EPS and FY2023 earnings at ($0.22) EPS.

A number of other brokerages have also recently issued reports on CYRX. SVB Leerink lowered their price objective on Cryoport from $45.00 to $28.00 and set an “outperform” rating for the company in a research note on Friday, November 4th. KeyCorp decreased their price objective on Cryoport from $52.00 to $40.00 and set an “overweight” rating on the stock in a research report on Friday, November 4th. Needham & Company LLC cut their target price on Cryoport from $49.00 to $28.00 and set a “buy” rating on the stock in a research note on Friday, November 4th. Finally, B. Riley dropped their price objective on Cryoport from $55.00 to $30.00 and set a “buy” rating on the stock in a research note on Wednesday, November 16th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Cryoport has an average rating of “Buy” and a consensus target price of $42.17.

Cryoport Price Performance

CYRX opened at $18.55 on Monday. The firm has a market cap of $908.95 million, a price-to-earnings ratio of -3.02 and a beta of 1.29. Cryoport has a 1 year low of $15.79 and a 1 year high of $75.00. The stock’s 50 day simple moving average is $24.94 and its 200 day simple moving average is $29.15. The company has a debt-to-equity ratio of 0.75, a current ratio of 14.96 and a quick ratio of 14.35.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Harbor Investment Advisory LLC grew its stake in shares of Cryoport by 69.7% in the second quarter. Harbor Investment Advisory LLC now owns 886 shares of the consumer goods maker’s stock worth $27,000 after acquiring an additional 364 shares in the last quarter. First Horizon Advisors Inc. boosted its stake in Cryoport by 132.3% in the first quarter. First Horizon Advisors Inc. now owns 1,080 shares of the consumer goods maker’s stock valued at $38,000 after acquiring an additional 615 shares in the last quarter. Point72 Hong Kong Ltd acquired a new position in Cryoport in the third quarter valued at $27,000. Nisa Investment Advisors LLC raised its holdings in shares of Cryoport by 357.1% in the second quarter. Nisa Investment Advisors LLC now owns 1,280 shares of the consumer goods maker’s stock valued at $40,000 after buying an additional 1,000 shares during the last quarter. Finally, Captrust Financial Advisors raised its holdings in shares of Cryoport by 308.3% in the second quarter. Captrust Financial Advisors now owns 2,319 shares of the consumer goods maker’s stock valued at $72,000 after buying an additional 1,751 shares during the last quarter. 90.33% of the stock is owned by hedge funds and other institutional investors.

About Cryoport

(Get Rating)

Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.

Featured Articles

Earnings History and Estimates for Cryoport (NASDAQ:CYRX)

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.